Navigating the “Thy” of the Storm: Management of Thyrotoxicosis
Thyrotoxicosis is an endocrine condition of excess thyroid hormone that has many etiologies and manifestations. Thyroid storm represents the severe end of the thyrotoxicosis spectrum and is uncommon, accounting for only 1% to 2% of hospital admissions for thyrotoxicosis, but requires prompt diagnosis and management. The American Thyroid Association (ATA) released updated guidelines in 2016 on the Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. By having an understanding of thyroid storm and the treatment, pharmacists can help provide recommendations and expedite medications to help improve patient care and outcomes. This CE presentation will educate pharmacists on the most up-to-date, evidence-based, guideline-recommended approach to managing thyroid storm.
Learning Objectives
Upon completion of this activity, the participant will be able to:
- Explain the pathophysiology and diagnosis of thyroid storm.
- Discuss guideline recommended treatment options and supportive care for the management of thyroid storm.
- Identify optimal outpatient monitoring and follow-up after the initial management of thyroid storm.
Presenter
Emily Duff, PharmD, is a PGY1 Pharmacy Resident at Baystate Medical Center in Springfield, Massachusetts. Emily is originally from Massachusetts and earned her Doctor of Pharmacy degree in May 2021 from the University of Rhode Island. Emily’s primary interest areas include critical care, emergency medicine, and academia. Emily early committed to the PGY2 Critical Care Pharmacy Residency at Baystate Medical Center for 2021-2022.
Registration Fee: This module is provided free of charge to all.
Release Date: June 16, 2022
Expiration Date: June 16, 2023
ACPE UAN: 0026-0000-22-135-L01-P| Knowledge
ACPE Topic Designator: Disease State Management/Drug Therapy
Contact Hours: 1.0 (0.1 CEU)
Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Massachusetts College of Pharmacy and Health Sciences designates this educational activity for a total of 1.0 contact hour (0.1 CEUs).
Emily Duff has no financial relationships with ineligible companies.
Residency Director Frank Szcerba has no financial relationships with ineligible companies.
Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies related to the content of this presentation.
Massachusetts College of Pharmacy and Health Sciences will identify, review, and mitigate all conflicts of interest disclosed prior to delivery of an educational activity to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation, but provides participants with information that may be of potential importance when they are evaluating content.